Gedeon Richter PLC (BUSE: RICHTER)
Health Care · Pharmaceuticals · HU
Ft13,330.00
+3.49% today · +25.9% 1Y
Gedeon Richter PLC (BUSE: RICHTER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $7.82B.
Over the last twelve months the share price has gained 25.9%, trading between 9.38K and 13.40K.
Tweenvest scores Gedeon Richter PLC across four factors: quality 90/100, value 43/100, growth 58/100, dividend 90/100. Its strongest factor is quality.
RICHTER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.82B
- Revenue (TTM)
- $2.97B
- P/E
- 11.29
- EPS
- 1,180.33
- Dividend yield
- 3.94%
- Beta (5Y)
- 0.34
- 52-week high
- Ft13,400.00
- 52-week low
- Ft9,380.00
- Avg volume (3M)
- —
- Shares outstanding
- 182.39M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,247.00 | +0.01% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $270.56 | -0.91% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.67 | +0.67% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.70 | +0.08% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £122.08 | +0.81% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.92 | -0.18% |
Figures last refreshed Aug 18, 2026.